Mckesson (MCK) Return on Capital Employed (2009 - 2026)
Mckesson's (MCK) quarterly Return on Capital Employed came in at 38.25% in Q1 2026, down 18.0% year-on-year from 46.65% in Q1 2025, and up 8.57% on a QoQ basis from 35.23% in Q4 2025.
Mckesson (MCK) Return on Capital Employed (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Return on Capital Employed data on file, last reported at 38.25% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 18.0% year-over-year to 38.25% in Q1 2026; TTM through Mar 2026 was 38.25%, a 18.0% decrease from a year earlier, with the FY2026 full-year figure at 53.03%, up 738.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 38.25%, up from 35.23% in the prior quarter.
- Over the last five years, Return on Capital Employed for MCK reached as high as 38.43% in Q1 2025 and fell as low as 13.55% in Q1 2022.
- Historically, Return on Capital Employed has averaged 28.62% across 5 years, with a median of 30.06% in 2023.
- Across the five-year window, Return on Capital Employed soared 5211 bps in 2022 and tumbled 454 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 27.11% in 2022, then decreased by 7 bps to 25.09% in 2023, then grew by 22 bps to 30.68% in 2024, then gained by 15 bps to 35.23% in 2025, then grew by 9 bps to 38.25% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 38.25% in Q1 2026, 35.23% in Q4 2025, and 35.76% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 38.25% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 11.68% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 15.02% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 8.29% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -0.62% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.01% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -67.59% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 64.08% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -60.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.25% |
| Dec 31, 2025 | 35.23% |
| Sep 30, 2025 | 35.76% |
| Jun 30, 2025 | 31.88% |
| Mar 31, 2025 | 38.43% |
| Dec 31, 2024 | 30.68% |
| Sep 30, 2024 | 26.09% |
| Jun 30, 2024 | 29.25% |
| Mar 31, 2024 | 26.74% |
| Dec 31, 2023 | 25.09% |
| Sep 30, 2023 | 30.63% |
| Jun 30, 2023 | 30.06% |
| Mar 31, 2023 | 30.11% |
| Dec 31, 2022 | 27.11% |
| Sep 30, 2022 | 21.57% |
| Jun 30, 2022 | 16.07% |
| Mar 31, 2022 | 13.55% |
| Dec 31, 2021 | 14.91% |
| Sep 30, 2021 | -30.54% |
| Jun 30, 2021 | -25.60% |